Balamurali K. Ambati,Bruce K. Gale,Srinivas Rao Chennamaneni
申请号：
US15590868
公开号：
US20170239272A1
申请日:
2017.05.09
申请国别(地区):
US
年份:
2017
代理人:
摘要：
An intraocular active agent delivery device can include an active agent homogenously combined with a biodegradable active agent matrix such that the entire delivery device is homogenous. The homogenous delivery device can have a shape and size to fit within a lens capsule or ciliary sulcus of an eye and provide a therapeutically effective amount of the active agent to the eye. The biodegradable active agent matrix can be formulated to provide sustained release of the therapeutically effective amount of the active agent during a release period. In some examples, the active agent can include dexamethasone.
